| dog |
LD50 |
intravenous |
60mg/kg (60mg/kg) |
|
Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 186, 1979. |
| mouse |
LD50 |
intraperitoneal |
> 200mg/kg (200mg/kg) |
|
Farmaco, Edizione Scientifica. Vol. 41, Pg. 80, 1986. |
| mouse |
LD50 |
intravenous |
62mg/kg (62mg/kg) |
|
United States Patent Document. Vol. #4252984, |
| mouse |
LD50 |
oral |
1050mg/kg (1050mg/kg) |
|
United States Patent Document. Vol. #4252984, |
| mouse |
LD50 |
subcutaneous |
> 600mg/kg (600mg/kg) |
|
Collection of Czechoslovak Chemical Communications. Vol. 50, Pg. 2289, 1985. |
| rat |
LD50 |
intravenous |
71900ug/kg (71.9mg/kg) |
|
Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 14, Pg. 321, 1977. |
| rat |
LD50 |
oral |
3470mg/kg (3470mg/kg) |
|
Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 14, Pg. 321, 1977. |
| women |
TDLo |
oral |
17mg/kg/17D-I (17mg/kg) |
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: EXCITEMENT |
Annals of Internal Medicine. Vol. 108, Pg. 67, 1988. |
| women |
TDLo |
oral |
150mg/kg (150mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
BEHAVIORAL: SLEEP
CARDIAC: CHANGE IN FORCE OF CONTRACTION |
Acta Medica Scandinavica. Vol. 218, Pg. 525, 1985. |
